Anirban Basu
Anirban Basu
Verified email at uw.edu - Homepage
Title
Cited by
Cited by
Year
Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and medicine
GD Sanders, PJ Neumann, A Basu, DW Brock, D Feeny, M Krahn, ...
Jama 316 (10), 1093-1103, 2016
15452016
Continuous glucose monitoring and intensive treatment of type 1 diabetes
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group
New England Journal of Medicine 359 (14), 1464-1476, 2008
15422008
Two-stage residual inclusion estimation: addressing endogeneity in health econometric modeling
JV Terza, A Basu, PJ Rathouz
Journal of health economics 27 (3), 531-543, 2008
14342008
Cost-effectiveness in health and medicine
PJ Neumann, GD Sanders, LB Russell, JE Siegel, TG Ganiats
Oxford University Press, 2016
7582016
Generalized modeling approaches to risk adjustment of skewed outcomes data
WG Manning, A Basu, J Mullahy
Journal of health economics 24 (3), 465-488, 2005
7552005
Projecting the future diabetes population size and related costs for the US
ES Huang, A Basu, M O'Grady, JC Capretta
Diabetes Care 32 (12), 2225-2229, 2009
4692009
Estimating marginal and incremental effects on health outcomes using flexible link and variance function models
A Basu, PJ Rathouz
Biostatistics 6 (1), 93-109, 2005
3342005
Estimating the medical care costs of obesity in the United States: systematic review, meta-analysis, and empirical analysis
DD Kim, A Basu
Value in Health 19 (5), 602-613, 2016
3072016
The effect of the Medicare Part D prescription benefit on drug utilization and expenditures
W Yin, A Basu, JX Zhang, A Rabbani, DO Meltzer, GC Alexander
Annals of internal medicine 148 (3), 169-177, 2008
2392008
Defining elements of value in health care—a health economics approach: an ISPOR Special Task Force report [3]
DN Lakdawalla, JA Doshi, LP Garrison Jr, CE Phelps, A Basu, ...
Value in Health 21 (2), 131-139, 2018
2142018
Use of instrumental variables in the presence of heterogeneity and self‐selection: an application to treatments of breast cancer patients
A Basu, JJ Heckman, S Navarro‐Lozano, S Urzua
Health economics 16 (11), 1133-1157, 2007
1952007
Use of instrumental variables in the presence of heterogeneity and self-selection: an application in breast cancer patients
A Basu, JJ Heckman, S Navarro-Lozano, S Urzua
195*2006
Comparing alternative models: log vs Cox proportional hazard?
A Basu, WG Manning, J Mullahy
Health economics 13 (8), 749-765, 2004
1802004
Protective and vulnerability factors predicting new-onset depressive episode in a representative of US adolescents
BW Van Voorhees, D Paunesku, SA Kuwabara, A Basu, J Gollan, ...
Journal of Adolescent Health 42 (6), 605-616, 2008
1702008
Protective and vulnerability factors predicting new-onset depressive episode in a representative of US adolescents
BW Van Voorhees, D Paunesku, SA Kuwabara, A Basu, J Gollan, ...
Journal of Adolescent Health 42 (6), 605-616, 2008
1702008
Issues for the next generation of health care cost analyses
A Basu, WG Manning
Medical care, S109-S114, 2009
1582009
Value of information on preference heterogeneity and individualized care
A Basu, D Meltzer
Medical Decision Making 27 (2), 112-127, 2007
1582007
Risk stratification for sudden cardiac death: a plan for the future
JJ Goldberger, A Basu, R Boineau, AE Buxton, ME Cain, JM Canty Jr, ...
Circulation 129 (4), 516-526, 2014
1502014
Highlighting differences between conditional and unconditional quantile regression approaches through an application to assess medication adherence
BJ Borah, A Basu
Health economics 22 (9), 1052-1070, 2013
1492013
Health literacy as a predictor of follow-up after an abnormal pap smear
ST Lindau, A Basu, SA Leitsch
Journal of general internal medicine 21 (8), 829-834, 2006
1482006
The system can't perform the operation now. Try again later.
Articles 1–20